This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form.

This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form. The article ...

For the study, researchers followed 262 adults who were prescribed GLP-1 medications like semaglutide or liraglutide to help with weight loss. The researchers also tracked changes in alcohol use to ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision to declare the end of the shortage of Novo Nordisk’s semaglutide, Judge ...

US court decision stops compounders from making knockoffs of Novo Nordisk's semaglutide On the compounded GLP-1 situation, Novo noted that the FDA removed semaglutide injectables from its shortage ...

Long view: Oral GLP-1 medications for obesity will be the next wave of innovation, and we think Novo is in a solid position, with the launch of oral semaglutide in obesity likely in 2026.

Long view: Oral GLP-1 medications for obesity will be the next wave of innovation, and we think Novo is in a solid position, with the launch of oral semaglutide in obesity likely in 2026.